| Literature DB >> 26690197 |
Xin Zhang1, Yan Xu2, Lian Zhou3, Chengcheng Zhang4, Qingtao Meng5, Shenshen Wu6, Shizhi Wang7, Zhen Ding8, Xiaodong Chen9, Xiaobo Li10, Rui Chen11.
Abstract
Ultrafine aluminum oxide, which are abundant in ambient and involved occupational environments, are associated with neurobehavioral alterations. However, few studies have focused on the effect of sex differences following exposure to environmental Al₂O₃ ultrafine particles. In the present study, male and female mice were exposed to Al₂O₃ nanoparticles (NPs) through a respiratory route. Only the female mice showed depression-like behavior. Although no obvious pathological changes were observed in mice brain tissues, the neurotransmitter and voltage-gated ion channel related gene expression, as well as the small molecule metabolites in the cerebral cortex, were differentially modulated between male and female mice. Both mental disorder-involved gene expression levels and metabolomics analysis results strongly suggested that glutamate pathways were implicated in sex differentiation induced by Al₂O₃ NPs. Results demonstrated the potential mechanism of environmental ultrafine particle-induced depression-like behavior and the importance of sex dimorphism in the toxic research of environmental chemicals.Entities:
Keywords: aluminum oxide; depressive; glutamate; nanoparticles; sex difference
Mesh:
Substances:
Year: 2015 PMID: 26690197 PMCID: PMC4690947 DOI: 10.3390/ijerph121215011
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Emotional behavioral tests of mice treated by Al2O3 NPs. (A): female mice showed less duration in central zone and increased duration in periphery zone in OFT on treatment day 14, (B): On the treatment day 28, results were consistent with day 14, (C): female mice showed increased immobile duration in FST on treatment day 14 and 28. * p < 0.05, compared with control of corresponding sex, n = 10.
Figure 2Aluminum burden in cortex, midbrain, and lung tissues of mice. * p < 0.05, compared with the corresponding sex control, n = 4.
Severity of lesions in lung tissues response to nano Al2O3 treatment.
| Group | Lesion Severity Grade | Average Severity Grade | |||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||
| male control | 4 | 1 | |||
| female control | 4 | 1 | |||
| male nano-Al2O3 | 3 | 1 | 2.25 ± 0.50 | ||
| female nano-Al2O3 | 2 | 2 | 2.5 ± 0.58 | ||
* p < 0.05, compared with the corresponding sex control, n = 4.
Figure 3Pathology of mice lung tissues following Al2O3 treatment. (A): control; (B): arrows showed ruptured alveolar walls and fusion of pulmonary alveoli; (C): arrows showed pneumorrhagia in lung tissues; (D): arrows demonstrated lymphocyte infiltration in lung tissues.
Fold induction of modulated genes in mice cortex.
| Control | Treatment | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | F Value | ||||||
| Fold Change | Fold Change | Fold Change | Fold Change | Treatment | Sex | Interaction | Treatment | Sex | Interaction | |
| SNAP29 | 1.03 ± 0.10 | 1.02 ± 0.12 | 0.95 ± 0.11 | 0.62±0.14 | 24.64 | 12.36 | 10.95 & | <0.0001 | 0.0022 | 0.0035 |
| UFD1L | 1.01 ± 0.07 | 1.02 ± 0.06 | 0.61 ± 0.08 | 0.65±0.08 | 167.00 | 0.7042 | 0.2535 | <0.0001 | 0.4113 | 0.6201 |
| ZDHHC8 | 1.04 ± 0.05 | 1.05 ± 0.07 | 0.95 ± 0.07 | 0.58±0.06 | 131.40 | 41.09 | 46.23 & | <0.0001 | <0.0001 | <0.0001 |
| PDLIM5 | 1.01 ± 0.08 | 1.05 ± 0.10 | 0.71 ± 0.10 | 0.82±0.14 | 36.64 | 2.935 | 0.639 | <0.0001 | 0.1022 | 0.4334 |
| HSPA1A | 1.06 ± 0.10 | 0.99 ± 0.07 | 0.54 ± 0.11 | 0.56±0.09 | 154.30 | 0.4273 | 1.385 | <0.0001 | 0.5207 | 0.2531 |
| PTEN | 0.99 ± 0.08 | 1.03 ± 0.09 | 0.63 ± 0.11 | 0.67±0.12 | 75.86 | 0.94 | 0.00 | <0.0001 | 0.3447 | 1.0000 |
| GDNF | 1.01 ± 0.07 | 0.98 ± 0.05 | 0.65 ± 0.06 | 0.32±0.14 | 204.00 | 25.41 | 17.65 & | <0.0001 | <0.0001 | 0.0004 |
| SOD2 | 0.97 ± 0.06 | 0.99 ± 0.08 | 0.67 ± 0.12 | 0.56±0.07 | 109.10 | 1.66 | 3.46 | <0.0001 | 0.2125 | 0.0776 |
| GNAS | 1.01 ± 0.09 | 1.06 ± 0.12 | 0.88 ± 0.15 | 0.70±0.14 | 22.30 | 1.57 | 4.91 & | 0.0001 | 0.2247 | 0.0384 |
| NOS3 | 0.96 ± 0.11 | 1.00 ± 0.04 | 0.71 ± 0.08 | 0.93±0.15 # | 14.42 | 9.52 | 4.56 & | 0.0011 | 0.0058 | 0.0452 |
| DLST | 1.01 ± 0.04 | 0.97 ± 0.06 | 0.91 ± 0.12 | 0.87±0.06 | 10.34 | 1.66 | 0.00 | 0.0043 | 0.2130 | 1.0000 |
| GRIN2A | 0.97 ± 0.08 | 1.01 ± 0.06 | 1.10 ± 0.18 | 2.78±0.17 | 423.70 | 317.70 | 288.20 & | <0.0001 | <0.0001 | <0.0001 |
| DGKH | 1.01 ± 0.04 | 1.06 ± 0.09 | 2.14 ± 0.09 | 0.72±0.06 | 175.00 | 526.21 | 605.94 & | <0.0001 | <0.0001 | <0.0001 |
| MT2A | 1.01 ± 0.07 | 1.02 ± 0.15 | 1.98 ± 0.07 | 2.34±0.13 | 639.50 | 16.70 | 14.94 & | 0.0010 | 0.0006 | <0.0001 |
| CACNA1G | 1.04 ± 0.07 | 1.03 ± 0.06 | 2.77 ± 0.13 | 0.75±0.12 | 516.75 | 938.68 | 887.50 & | <0.0001 | <0.0001 | <0.0001 |
| KCNQ | 1.00 ± 0.04 | 0.97 ± 0.08 | 2.86 ± 0.10 | 0.72±0.11 | 317.03 | 621.19 | 609.14 & | <0.0001 | <0.0001 | <0.0001 |
* p < 0.05, compared with corresponding sex control, # p < 0.05, compared with male Al2O3 NP treated mice, & p < 0.05, sex and Al2O3 NPs treatment showed interaction effect, df = 5.
Metabolomics analysis of Al2O3NP-treated mice cortex.
| Metabolite | HMDB ID | Fold Change | Male Al2O3 NPs | Female Al2O3 NPs | |||||
|---|---|---|---|---|---|---|---|---|---|
| Male Al2O3 NPs | Female Control | Female Al2O3 NPs | F Value | F Value | |||||
| L-Serine | HMDB00187 | 1.98 | 1.03 | 4.26 # | 13.63 | 0.002 | 53.54 | <0.0001 | |
| Dihydroxy acetone Phosphate | HMDB01473 | - | 0.83 | 2.97 # | 0.43 | 0.5261 | 14.9 | 0.0017 | |
| Inosine | HMDB00195 | 2.05 | 1.14 | 2.61 | 12.68 | 0.0022 | 13.01 | 0.0019 | |
| Prostaglandin E2 | HMDB01220 | 2.43 | 1.27 | 4.02 | 22.31 | 0.0001 | 49.69 | <0.0001 | |
| Acetyl-L-Carnitine | HMDB00201 | 2.37 | 0.96 | 3.86 | 28.74 | <0.0001 | 37.21 | <0.0001 | |
| Pyroglutamic Acid | HMDB00267 | 2.53 | 0.89 | 0.52 # | 32.57 | <0.0001 | 24.52 | <0.0001 | |
| Riboflavin | HMDB00244 | 3.83 | 1.07 | 2.18 | 36.53 | <0.0001 | 27.73 | <0.0001 | |
| Inosine 5-Monophosphate | HMDB00175 | 1.89 | 0.93 | 1.68 | 11.42 | 0.0026 | 9.52 | 0.0058 | |
| HMDB00148 | - | 1.08 | 0.17 # | 1.69 | 0.2125 | 103.89 | <0.0001 | ||
| 7b-Hydroxycholesterol | HMDB06119 | 0.48 | 0.77 | - | 28.49 | <0.0001 | 0.89 | 0.4213 | |
| 2-Hydroxyestrone | HMDB00343 | - | 0.98 | 0.48 | 0.25 | 0.6178 | 41.25 | <0.0001 | |
| Dl-Glyceraldehyde | HMDB01051 | 0.3 | 1.06 | 0.46 | 59.77 | <0.0001 | 38.56 | <0.0001 | |
| Petroselinic Acid | HMDB02080 | 0.21 | 1.18 | 0.48 | 75.86 | <0.0001 | 42.59 | <0.0001 | |
# p < 0.05, compared with male Al2O3 NPs treatment, df = 5.